SMART Health Cards: Terminology
0.1.0 - ci-build
SMART Health Cards: Terminology, published by VCI. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/dvci/shc-terminology/ and changes regularly. See the Directory of published versions
| Draft as of 2024-11-22 |
{
"resourceType" : "ValueSet",
"id" : "immunization-all-cvx",
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n \n <p>\n The following codes from the <code><a href=\"http://terminology.hl7.org/6.1.0/CodeSystem-CVX.html\">http://hl7.org/fhir/sid/cvx</a></code> code system are included:\n </p>\n <table class=\"table-striped table table-bordered\">\n <tr>\n <th>Code</th>\n <th>Description(s)</th>\n </tr>\n \n <tr>\n <td><code>54</code></td>\n <td>\n \n adenovirus, type 4\n \n </td>\n </tr>\n \n <tr>\n <td><code>55</code></td>\n <td>\n \n adenovirus, type 7\n \n </td>\n </tr>\n \n <tr>\n <td><code>82</code></td>\n <td>\n \n adenovirus, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>24</code></td>\n <td>\n \n anthrax\n \n </td>\n </tr>\n \n <tr>\n <td><code>19</code></td>\n <td>\n \n BCG\n \n </td>\n </tr>\n \n <tr>\n <td><code>27</code></td>\n <td>\n \n botulinum antitoxin\n \n </td>\n </tr>\n \n <tr>\n <td><code>26</code></td>\n <td>\n \n cholera, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>29</code></td>\n <td>\n \n CMVIG\n \n </td>\n </tr>\n \n <tr>\n <td><code>56</code></td>\n <td>\n \n dengue fever tetravalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>12</code></td>\n <td>\n \n diphtheria antitoxin\n \n </td>\n </tr>\n \n <tr>\n <td><code>28</code></td>\n <td>\n \n DT (pediatric)\n \n </td>\n </tr>\n \n <tr>\n <td><code>20</code></td>\n <td>\n \n DTaP\n \n </td>\n </tr>\n \n <tr>\n <td><code>106</code></td>\n <td>\n \n DTaP, 5 pertussis antigens\n \n </td>\n </tr>\n \n <tr>\n <td><code>107</code></td>\n <td>\n \n DTaP, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>110</code></td>\n <td>\n \n DTaP-Hep B-IPV\n \n </td>\n </tr>\n \n <tr>\n <td><code>50</code></td>\n <td>\n \n DTaP-Hib\n \n </td>\n </tr>\n \n <tr>\n <td><code>120</code></td>\n <td>\n \n DTaP-Hib-IPV\n \n </td>\n </tr>\n \n <tr>\n <td><code>130</code></td>\n <td>\n \n DTaP-IPV\n \n </td>\n </tr>\n \n <tr>\n <td><code>1</code></td>\n <td>\n \n DTP\n \n </td>\n </tr>\n \n <tr>\n <td><code>22</code></td>\n <td>\n \n DTP-Hib\n \n </td>\n </tr>\n \n <tr>\n <td><code>102</code></td>\n <td>\n \n DTP-Hib-Hep B\n \n </td>\n </tr>\n \n <tr>\n <td><code>57</code></td>\n <td>\n \n hantavirus\n \n </td>\n </tr>\n \n <tr>\n <td><code>52</code></td>\n <td>\n \n Hep A, adult\n \n </td>\n </tr>\n \n <tr>\n <td><code>83</code></td>\n <td>\n \n Hep A, ped/adol, 2 dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>84</code></td>\n <td>\n \n Hep A, ped/adol, 3 dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>31</code></td>\n <td>\n \n Hep A, pediatric, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>85</code></td>\n <td>\n \n Hep A, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>104</code></td>\n <td>\n \n Hep A-Hep B\n \n </td>\n </tr>\n \n <tr>\n <td><code>30</code></td>\n <td>\n \n HBIG\n \n </td>\n </tr>\n \n <tr>\n <td><code>8</code></td>\n <td>\n \n Hep B, adolescent or pediatric\n \n </td>\n </tr>\n \n <tr>\n <td><code>42</code></td>\n <td>\n \n Hep B, adolescent/high risk infant\n \n </td>\n </tr>\n \n <tr>\n <td><code>43</code></td>\n <td>\n \n Hep B, adult\n \n </td>\n </tr>\n \n <tr>\n <td><code>44</code></td>\n <td>\n \n Hep B, dialysis\n \n </td>\n </tr>\n \n <tr>\n <td><code>45</code></td>\n <td>\n \n Hep B, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>58</code></td>\n <td>\n \n Hep C\n \n </td>\n </tr>\n \n <tr>\n <td><code>59</code></td>\n <td>\n \n Hep E\n \n </td>\n </tr>\n \n <tr>\n <td><code>60</code></td>\n <td>\n \n herpes simplex 2\n \n </td>\n </tr>\n \n <tr>\n <td><code>46</code></td>\n <td>\n \n Hib (PRP-D)\n \n </td>\n </tr>\n \n <tr>\n <td><code>47</code></td>\n <td>\n \n Hib (HbOC)\n \n </td>\n </tr>\n \n <tr>\n <td><code>48</code></td>\n <td>\n \n Hib (PRP-T)\n \n </td>\n </tr>\n \n <tr>\n <td><code>49</code></td>\n <td>\n \n Hib (PRP-OMP)\n \n </td>\n </tr>\n \n <tr>\n <td><code>17</code></td>\n <td>\n \n Hib, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>51</code></td>\n <td>\n \n Hib-Hep B\n \n </td>\n </tr>\n \n <tr>\n <td><code>61</code></td>\n <td>\n \n HIV\n \n </td>\n </tr>\n \n <tr>\n <td><code>118</code></td>\n <td>\n \n HPV, bivalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>62</code></td>\n <td>\n \n HPV, quadrivalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>86</code></td>\n <td>\n \n IG\n \n </td>\n </tr>\n \n <tr>\n <td><code>87</code></td>\n <td>\n \n IGIV\n \n </td>\n </tr>\n \n <tr>\n <td><code>14</code></td>\n <td>\n \n IG, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>111</code></td>\n <td>\n \n influenza, live, intranasal\n \n </td>\n </tr>\n \n <tr>\n <td><code>15</code></td>\n <td>\n \n influenza, split (incl. purified surface antigen)\n \n </td>\n </tr>\n \n <tr>\n <td><code>16</code></td>\n <td>\n \n influenza, whole\n \n </td>\n </tr>\n \n <tr>\n <td><code>88</code></td>\n <td>\n \n influenza, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>123</code></td>\n <td>\n \n influenza, H5N1-1203\n \n </td>\n </tr>\n \n <tr>\n <td><code>10</code></td>\n <td>\n \n IPV\n \n </td>\n </tr>\n \n <tr>\n <td><code>2</code></td>\n <td>\n \n OPV\n \n </td>\n </tr>\n \n <tr>\n <td><code>89</code></td>\n <td>\n \n polio, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>39</code></td>\n <td>\n \n Japanese encephalitis SC\n \n </td>\n </tr>\n \n <tr>\n <td><code>63</code></td>\n <td>\n \n Junin virus\n \n </td>\n </tr>\n \n <tr>\n <td><code>64</code></td>\n <td>\n \n leishmaniasis\n \n </td>\n </tr>\n \n <tr>\n <td><code>65</code></td>\n <td>\n \n leprosy\n \n </td>\n </tr>\n \n <tr>\n <td><code>66</code></td>\n <td>\n \n Lyme disease\n \n </td>\n </tr>\n \n <tr>\n <td><code>3</code></td>\n <td>\n \n MMR\n \n </td>\n </tr>\n \n <tr>\n <td><code>4</code></td>\n <td>\n \n M/R\n \n </td>\n </tr>\n \n <tr>\n <td><code>94</code></td>\n <td>\n \n MMRV\n \n </td>\n </tr>\n \n <tr>\n <td><code>67</code></td>\n <td>\n \n malaria\n \n </td>\n </tr>\n \n <tr>\n <td><code>5</code></td>\n <td>\n \n measles\n \n </td>\n </tr>\n \n <tr>\n <td><code>68</code></td>\n <td>\n \n melanoma\n \n </td>\n </tr>\n \n <tr>\n <td><code>32</code></td>\n <td>\n \n meningococcal MPSV4\n \n </td>\n </tr>\n \n <tr>\n <td><code>103</code></td>\n <td>\n \n meningococcal C conjugate\n \n </td>\n </tr>\n \n <tr>\n <td><code>114</code></td>\n <td>\n \n meningococcal MCV4P\n \n </td>\n </tr>\n \n <tr>\n <td><code>108</code></td>\n <td>\n \n meningococcal ACWY, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>7</code></td>\n <td>\n \n mumps\n \n </td>\n </tr>\n \n <tr>\n <td><code>69</code></td>\n <td>\n \n parainfluenza-3\n \n </td>\n </tr>\n \n <tr>\n <td><code>11</code></td>\n <td>\n \n pertussis\n \n </td>\n </tr>\n \n <tr>\n <td><code>23</code></td>\n <td>\n \n plague\n \n </td>\n </tr>\n \n <tr>\n <td><code>33</code></td>\n <td>\n \n pneumococcal polysaccharide PPV23\n \n </td>\n </tr>\n \n <tr>\n <td><code>100</code></td>\n <td>\n \n pneumococcal conjugate PCV 7\n \n </td>\n </tr>\n \n <tr>\n <td><code>109</code></td>\n <td>\n \n pneumococcal, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>70</code></td>\n <td>\n \n Q fever\n \n </td>\n </tr>\n \n <tr>\n <td><code>18</code></td>\n <td>\n \n rabies, intramuscular injection\n \n </td>\n </tr>\n \n <tr>\n <td><code>40</code></td>\n <td>\n \n rabies, intradermal injection\n \n </td>\n </tr>\n \n <tr>\n <td><code>90</code></td>\n <td>\n \n rabies, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>72</code></td>\n <td>\n \n rheumatic fever\n \n </td>\n </tr>\n \n <tr>\n <td><code>73</code></td>\n <td>\n \n Rift Valley fever\n \n </td>\n </tr>\n \n <tr>\n <td><code>34</code></td>\n <td>\n \n RIG\n \n </td>\n </tr>\n \n <tr>\n <td><code>119</code></td>\n <td>\n \n rotavirus, monovalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>122</code></td>\n <td>\n \n rotavirus, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>116</code></td>\n <td>\n \n rotavirus, pentavalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>74</code></td>\n <td>\n \n rotavirus, tetravalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>71</code></td>\n <td>\n \n RSV-IGIV\n \n </td>\n </tr>\n \n <tr>\n <td><code>93</code></td>\n <td>\n \n RSV-MAb\n \n </td>\n </tr>\n \n <tr>\n <td><code>6</code></td>\n <td>\n \n rubella\n \n </td>\n </tr>\n \n <tr>\n <td><code>38</code></td>\n <td>\n \n rubella/mumps\n \n </td>\n </tr>\n \n <tr>\n <td><code>76</code></td>\n <td>\n \n Staphylococcus bacterio lysate\n \n </td>\n </tr>\n \n <tr>\n <td><code>113</code></td>\n <td>\n \n Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed\n \n </td>\n </tr>\n \n <tr>\n <td><code>9</code></td>\n <td>\n \n Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed\n \n </td>\n </tr>\n \n <tr>\n <td><code>115</code></td>\n <td>\n \n Tdap\n \n </td>\n </tr>\n \n <tr>\n <td><code>35</code></td>\n <td>\n \n tetanus toxoid, adsorbed\n \n </td>\n </tr>\n \n <tr>\n <td><code>112</code></td>\n <td>\n \n tetanus toxoid, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>77</code></td>\n <td>\n \n Tick-borne encephalitis vaccine (non-US)\n \n </td>\n </tr>\n \n <tr>\n <td><code>13</code></td>\n <td>\n \n TIG\n \n </td>\n </tr>\n \n <tr>\n <td><code>95</code></td>\n <td>\n \n TST-OT tine test\n \n </td>\n </tr>\n \n <tr>\n <td><code>96</code></td>\n <td>\n \n TST-PPD intradermal\n \n </td>\n </tr>\n \n <tr>\n <td><code>97</code></td>\n <td>\n \n TST-PPD tine test\n \n </td>\n </tr>\n \n <tr>\n <td><code>98</code></td>\n <td>\n \n TST, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>78</code></td>\n <td>\n \n tularemia vaccine\n \n </td>\n </tr>\n \n <tr>\n <td><code>91</code></td>\n <td>\n \n typhoid, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>25</code></td>\n <td>\n \n typhoid, oral\n \n </td>\n </tr>\n \n <tr>\n <td><code>41</code></td>\n <td>\n \n typhoid, parenteral\n \n </td>\n </tr>\n \n <tr>\n <td><code>53</code></td>\n <td>\n \n typhoid, parenteral, AKD (U.S. military)\n \n </td>\n </tr>\n \n <tr>\n <td><code>101</code></td>\n <td>\n \n typhoid, ViCPs\n \n </td>\n </tr>\n \n <tr>\n <td><code>75</code></td>\n <td>\n \n vaccinia (smallpox)\n \n </td>\n </tr>\n \n <tr>\n <td><code>105</code></td>\n <td>\n \n vaccinia (smallpox) diluted\n \n </td>\n </tr>\n \n <tr>\n <td><code>79</code></td>\n <td>\n \n vaccinia immune globulin\n \n </td>\n </tr>\n \n <tr>\n <td><code>21</code></td>\n <td>\n \n varicella\n \n </td>\n </tr>\n \n <tr>\n <td><code>81</code></td>\n <td>\n \n VEE, inactivated\n \n </td>\n </tr>\n \n <tr>\n <td><code>80</code></td>\n <td>\n \n VEE, live\n \n </td>\n </tr>\n \n <tr>\n <td><code>92</code></td>\n <td>\n \n VEE, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>36</code></td>\n <td>\n \n VZIG\n \n </td>\n </tr>\n \n <tr>\n <td><code>117</code></td>\n <td>\n \n VZIG (IND)\n \n </td>\n </tr>\n \n <tr>\n <td><code>37</code></td>\n <td>\n \n yellow fever\n \n </td>\n </tr>\n \n <tr>\n <td><code>121</code></td>\n <td>\n \n zoster live\n \n </td>\n </tr>\n \n <tr>\n <td><code>998</code></td>\n <td>\n \n no vaccine administered\n \n </td>\n </tr>\n \n <tr>\n <td><code>999</code></td>\n <td>\n \n unknown\n \n </td>\n </tr>\n \n <tr>\n <td><code>99</code></td>\n <td>\n \n RESERVED - do not use\n \n </td>\n </tr>\n \n <tr>\n <td><code>133</code></td>\n <td>\n \n Pneumococcal conjugate PCV 13\n \n </td>\n </tr>\n \n <tr>\n <td><code>134</code></td>\n <td>\n \n Japanese Encephalitis IM\n \n </td>\n </tr>\n \n <tr>\n <td><code>137</code></td>\n <td>\n \n HPV, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>136</code></td>\n <td>\n \n Meningococcal MCV4O\n \n </td>\n </tr>\n \n <tr>\n <td><code>135</code></td>\n <td>\n \n Influenza, high dose seasonal\n \n </td>\n </tr>\n \n <tr>\n <td><code>131</code></td>\n <td>\n \n typhus, historical\n \n </td>\n </tr>\n \n <tr>\n <td><code>132</code></td>\n <td>\n \n DTaP-IPV-HIB-HEP B, historical\n \n </td>\n </tr>\n \n <tr>\n <td><code>128</code></td>\n <td>\n \n Novel Influenza-H1N1-09, all formulations\n \n </td>\n </tr>\n \n <tr>\n <td><code>125</code></td>\n <td>\n \n Novel Influenza-H1N1-09, nasal\n \n </td>\n </tr>\n \n <tr>\n <td><code>126</code></td>\n <td>\n \n Novel influenza-H1N1-09, preservative-free\n \n </td>\n </tr>\n \n <tr>\n <td><code>127</code></td>\n <td>\n \n Novel influenza-H1N1-09\n \n </td>\n </tr>\n \n <tr>\n <td><code>138</code></td>\n <td>\n \n Td (adult)\n \n </td>\n </tr>\n \n <tr>\n <td><code>139</code></td>\n <td>\n \n Td(adult) unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>140</code></td>\n <td>\n \n Influenza, seasonal, injectable, preservative free\n \n </td>\n </tr>\n \n <tr>\n <td><code>129</code></td>\n <td>\n \n Japanese Encephalitis, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>141</code></td>\n <td>\n \n Influenza, seasonal, injectable\n \n </td>\n </tr>\n \n <tr>\n <td><code>142</code></td>\n <td>\n \n tetanus toxoid, not adsorbed\n \n </td>\n </tr>\n \n <tr>\n <td><code>143</code></td>\n <td>\n \n Adenovirus types 4 and 7\n \n </td>\n </tr>\n \n <tr>\n <td><code>144</code></td>\n <td>\n \n influenza, seasonal, intradermal, preservative free\n \n </td>\n </tr>\n \n <tr>\n <td><code>145</code></td>\n <td>\n \n RSV-MAb (new)\n \n </td>\n </tr>\n \n <tr>\n <td><code>146</code></td>\n <td>\n \n DTaP,IPV,Hib,HepB\n \n </td>\n </tr>\n \n <tr>\n <td><code>147</code></td>\n <td>\n \n meningococcal MCV4, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>148</code></td>\n <td>\n \n Meningococcal C/Y-HIB PRP\n \n </td>\n </tr>\n \n <tr>\n <td><code>149</code></td>\n <td>\n \n influenza, live, intranasal, quadrivalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>150</code></td>\n <td>\n \n influenza, injectable, quadrivalent, preservative free\n \n </td>\n </tr>\n \n <tr>\n <td><code>151</code></td>\n <td>\n \n influenza nasal, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>152</code></td>\n <td>\n \n Pneumococcal Conjugate, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>153</code></td>\n <td>\n \n Influenza, injectable, MDCK, preservative free\n \n </td>\n </tr>\n \n <tr>\n <td><code>154</code></td>\n <td>\n \n Hep A, IG\n \n </td>\n </tr>\n \n <tr>\n <td><code>155</code></td>\n <td>\n \n influenza, recombinant, injectable, preservative free\n \n </td>\n </tr>\n \n <tr>\n <td><code>156</code></td>\n <td>\n \n Rho(D)-IG\n \n </td>\n </tr>\n \n <tr>\n <td><code>157</code></td>\n <td>\n \n Rho(D) -IG IM\n \n </td>\n </tr>\n \n <tr>\n <td><code>158</code></td>\n <td>\n \n influenza, injectable, quadrivalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>159</code></td>\n <td>\n \n Rho(D) - Unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>160</code></td>\n <td>\n \n Influenza A monovalent (H5N1), ADJUVANTED-2013\n \n </td>\n </tr>\n \n <tr>\n <td><code>801</code></td>\n <td>\n \n AS03 Adjuvant\n \n </td>\n </tr>\n \n <tr>\n <td><code>161</code></td>\n <td>\n \n Influenza, injectable,quadrivalent, preservative free, pediatric\n \n </td>\n </tr>\n \n <tr>\n <td><code>162</code></td>\n <td>\n \n meningococcal B, recombinant\n \n </td>\n </tr>\n \n <tr>\n <td><code>163</code></td>\n <td>\n \n meningococcal B, OMV\n \n </td>\n </tr>\n \n <tr>\n <td><code>164</code></td>\n <td>\n \n meningococcal B, unspecified\n \n </td>\n </tr>\n \n <tr>\n <td><code>165</code></td>\n <td>\n \n HPV9\n \n </td>\n </tr>\n \n <tr>\n <td><code>166</code></td>\n <td>\n \n influenza, intradermal, quadrivalent, preservative free\n \n </td>\n </tr>\n \n <tr>\n <td><code>167</code></td>\n <td>\n \n meningococcal, unknown serogroups\n \n </td>\n </tr>\n \n <tr>\n <td><code>168</code></td>\n <td>\n \n influenza, trivalent, adjuvanted\n \n </td>\n </tr>\n \n <tr>\n <td><code>169</code></td>\n <td>\n \n Hep A, live attenuated\n \n </td>\n </tr>\n \n <tr>\n <td><code>170</code></td>\n <td>\n \n DTAP/IPV/HIB - non-US\n \n </td>\n </tr>\n \n <tr>\n <td><code>171</code></td>\n <td>\n \n Influenza, injectable, MDCK, preservative free, quadrivalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>172</code></td>\n <td>\n \n cholera, WC-rBS\n \n </td>\n </tr>\n \n <tr>\n <td><code>173</code></td>\n <td>\n \n cholera, BivWC\n \n </td>\n </tr>\n \n <tr>\n <td><code>174</code></td>\n <td>\n \n cholera, live attenuated\n \n </td>\n </tr>\n \n <tr>\n <td><code>175</code></td>\n <td>\n \n Rabies - IM Diploid cell culture\n \n </td>\n </tr>\n \n <tr>\n <td><code>176</code></td>\n <td>\n \n Rabies - IM fibroblast culture\n \n </td>\n </tr>\n \n <tr>\n <td><code>177</code></td>\n <td>\n \n PCV10\n \n </td>\n </tr>\n \n <tr>\n <td><code>178</code></td>\n <td>\n \n OPV bivalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>179</code></td>\n <td>\n \n OPV ,monovalent, unspecified\n \n </td>\n </tr>\n \n <tr>\n <td><code>180</code></td>\n <td>\n \n tetanus immune globulin\n \n </td>\n </tr>\n \n <tr>\n <td><code>181</code></td>\n <td>\n \n anthrax immune globulin\n \n </td>\n </tr>\n \n <tr>\n <td><code>182</code></td>\n <td>\n \n OPV, Unspecified\n \n </td>\n </tr>\n \n <tr>\n <td><code>183</code></td>\n <td>\n \n Yellow fever vaccine - alt\n \n </td>\n </tr>\n \n <tr>\n <td><code>184</code></td>\n <td>\n \n Yellow fever, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>185</code></td>\n <td>\n \n influenza, recombinant, quadrivalent,injectable, preservative free\n \n </td>\n </tr>\n \n <tr>\n <td><code>186</code></td>\n <td>\n \n Influenza, injectable, MDCK, quadrivalent, preservative\n \n </td>\n </tr>\n \n <tr>\n <td><code>187</code></td>\n <td>\n \n zoster recombinant\n \n </td>\n </tr>\n \n <tr>\n <td><code>188</code></td>\n <td>\n \n zoster, unspecified formulation\n \n </td>\n </tr>\n \n <tr>\n <td><code>189</code></td>\n <td>\n \n HepB-CpG\n \n </td>\n </tr>\n \n <tr>\n <td><code>190</code></td>\n <td>\n \n Typhoid conjugate vaccine (TCV)\n \n </td>\n </tr>\n \n <tr>\n <td><code>191</code></td>\n <td>\n \n meningococcal A polysaccharide (non-US)\n \n </td>\n </tr>\n \n <tr>\n <td><code>192</code></td>\n <td>\n \n meningococcal AC polysaccharide (non-US)\n \n </td>\n </tr>\n \n <tr>\n <td><code>193</code></td>\n <td>\n \n Hep A-Hep B, pediatric/adolescent\n \n </td>\n </tr>\n \n <tr>\n <td><code>194</code></td>\n <td>\n \n Influenza, Southern Hemisphere\n \n </td>\n </tr>\n \n <tr>\n <td><code>195</code></td>\n <td>\n \n DT, IPV adsorbed\n \n </td>\n </tr>\n \n <tr>\n <td><code>196</code></td>\n <td>\n \n Td, adsorbed, preservative free, adult use, Lf unspecified\n \n </td>\n </tr>\n \n <tr>\n <td><code>197</code></td>\n <td>\n \n influenza, high-dose, quadrivalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>200</code></td>\n <td>\n \n influenza, Southern Hemisphere, pediatric, preservative free\n \n </td>\n </tr>\n \n <tr>\n <td><code>201</code></td>\n <td>\n \n influenza, Southern Hemisphere, preservative free\n \n </td>\n </tr>\n \n <tr>\n <td><code>202</code></td>\n <td>\n \n influenza, Southern Hemisphere, quadrivalent, with preservative\n \n </td>\n </tr>\n \n <tr>\n <td><code>198</code></td>\n <td>\n \n DTP-hepB-Hib Pentavalent Non-US\n \n </td>\n </tr>\n \n <tr>\n <td><code>203</code></td>\n <td>\n \n meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)\n \n </td>\n </tr>\n \n <tr>\n <td><code>205</code></td>\n <td>\n \n Influenza vaccine, quadrivalent, adjuvanted\n \n </td>\n </tr>\n \n <tr>\n <td><code>206</code></td>\n <td>\n \n Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection\n \n </td>\n </tr>\n \n <tr>\n <td><code>207</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>208</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>213</code></td>\n <td>\n \n SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED\n \n </td>\n </tr>\n \n <tr>\n <td><code>210</code></td>\n <td>\n \n COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL \n \n </td>\n </tr>\n \n <tr>\n <td><code>212</code></td>\n <td>\n \n COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>204</code></td>\n <td>\n \n Ebola Zaire vaccine, live, recombinant, 1mL dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>214</code></td>\n <td>\n \n Ebola, unspecified\n \n </td>\n </tr>\n \n <tr>\n <td><code>211</code></td>\n <td>\n \n COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>500</code></td>\n <td>\n \n COVID-19 Non-US Vaccine, Product Unknown\n \n </td>\n </tr>\n \n <tr>\n <td><code>501</code></td>\n <td>\n \n COVID-19 IV Non-US Vaccine (QAZCOVID-IN)\n \n </td>\n </tr>\n \n <tr>\n <td><code>502</code></td>\n <td>\n \n COVID-19 IV Non-US Vaccine (COVAXIN)\n \n </td>\n </tr>\n \n <tr>\n <td><code>503</code></td>\n <td>\n \n COVID-19 LAV Non-US Vaccine (COVIVAC)\n \n </td>\n </tr>\n \n <tr>\n <td><code>504</code></td>\n <td>\n \n COVID-19 VVnr Non-US Vaccine (Sputnik Light)\n \n </td>\n </tr>\n \n <tr>\n <td><code>505</code></td>\n <td>\n \n COVID-19 VVnr Non-US Vaccine (Sputnik V)\n \n </td>\n </tr>\n \n <tr>\n <td><code>506</code></td>\n <td>\n \n COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology\n \n </td>\n </tr>\n \n <tr>\n <td><code>507</code></td>\n <td>\n \n COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)\n \n </td>\n </tr>\n \n <tr>\n <td><code>508</code></td>\n <td>\n \n COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)\n \n </td>\n </tr>\n \n <tr>\n <td><code>509</code></td>\n <td>\n \n COVID-19 PS Non-US Vaccine (EpiVacCorona)\n \n </td>\n </tr>\n \n <tr>\n <td><code>510</code></td>\n <td>\n \n COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)\n \n </td>\n </tr>\n \n <tr>\n <td><code>511</code></td>\n <td>\n \n COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)\n \n </td>\n </tr>\n \n <tr>\n <td><code>215</code></td>\n <td>\n \n Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF\n \n </td>\n </tr>\n \n <tr>\n <td><code>216</code></td>\n <td>\n \n Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF\n \n </td>\n </tr>\n \n <tr>\n <td><code>219</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose\n \n </td>\n </tr>\n \n <tr>\n <td><code>217</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose\n \n </td>\n </tr>\n \n <tr>\n <td><code>218</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose\n \n </td>\n </tr>\n \n <tr>\n <td><code>220</code></td>\n <td>\n \n HepB recombinant, 3-antigen, Al(OH)3\n \n </td>\n </tr>\n \n <tr>\n <td><code>221</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>222</code></td>\n <td>\n \n Tick-borne encephalitis, unspecified\n \n </td>\n </tr>\n \n <tr>\n <td><code>223</code></td>\n <td>\n \n Tick-borne encephalitis, inactivated, PF, 0.25mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>224</code></td>\n <td>\n \n Tick-borne encephalitis, inactivated, PF, 0.5mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>225</code></td>\n <td>\n \n COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>226</code></td>\n <td>\n \n COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>512</code></td>\n <td>\n \n SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)\n \n </td>\n </tr>\n \n <tr>\n <td><code>513</code></td>\n <td>\n \n SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)\n \n </td>\n </tr>\n \n <tr>\n <td><code>514</code></td>\n <td>\n \n SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)\n \n </td>\n </tr>\n \n <tr>\n <td><code>515</code></td>\n <td>\n \n SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)\n \n </td>\n </tr>\n \n <tr>\n <td><code>516</code></td>\n <td>\n \n COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)\n \n </td>\n </tr>\n \n <tr>\n <td><code>517</code></td>\n <td>\n \n SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)\n \n </td>\n </tr>\n \n <tr>\n <td><code>227</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>228</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>229</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>301</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>300</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose\n \n </td>\n </tr>\n \n <tr>\n <td><code>230</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>518</code></td>\n <td>\n \n COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)\n \n </td>\n </tr>\n \n <tr>\n <td><code>519</code></td>\n <td>\n \n COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna\n \n </td>\n </tr>\n \n <tr>\n <td><code>520</code></td>\n <td>\n \n COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech\n \n </td>\n </tr>\n \n <tr>\n <td><code>521</code></td>\n <td>\n \n COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK\n \n </td>\n </tr>\n \n <tr>\n <td><code>231</code></td>\n <td>\n \n influenza, Southern Hemisphere, high-dose, quadrivalent\n \n </td>\n </tr>\n \n <tr>\n <td><code>303</code></td>\n <td>\n \n RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF\n \n </td>\n </tr>\n \n <tr>\n <td><code>304</code></td>\n <td>\n \n Respiratory syncytial virus (RSV), unspecified \n \n </td>\n </tr>\n \n <tr>\n <td><code>305</code></td>\n <td>\n \n RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF\n \n </td>\n </tr>\n \n <tr>\n <td><code>306</code></td>\n <td>\n \n RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months\n \n </td>\n </tr>\n \n <tr>\n <td><code>307</code></td>\n <td>\n \n RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months\n \n </td>\n </tr>\n \n <tr>\n <td><code>313</code></td>\n <td>\n \n COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>308</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>309</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>310</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>312</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>311</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL\n \n </td>\n </tr>\n \n <tr>\n <td><code>302</code></td>\n <td>\n \n COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose\n \n </td>\n </tr>\n \n </table>\n \n</div>"
},
"url" : "https://terminology.smarthealth.cards/ValueSet/immunization-all-cvx",
"version" : "20230920",
"name" : "ImmunizationAllCvxValueSet",
"title" : "Immunization / All / CVX",
"status" : "draft",
"date" : "2024-11-22T10:58:52+00:00",
"publisher" : "VCI",
"contact" : [
{
"name" : "VCI",
"telecom" : [
{
"system" : "url",
"value" : "https://vci.org"
}
]
}
],
"description" : "Contains all CVX codes from <https://www2.cdc.gov/vaccines/iis/iisstandards/vaccines.asp?rpt=cvx> as of 2023-09-20.",
"compose" : {
"include" : [
{
"system" : "http://hl7.org/fhir/sid/cvx",
"concept" : [
{
"code" : "54",
"display" : "adenovirus, type 4"
},
{
"code" : "55",
"display" : "adenovirus, type 7"
},
{
"code" : "82",
"display" : "adenovirus, unspecified formulation"
},
{
"code" : "24",
"display" : "anthrax"
},
{
"code" : "19",
"display" : "BCG"
},
{
"code" : "27",
"display" : "botulinum antitoxin"
},
{
"code" : "26",
"display" : "cholera, unspecified formulation"
},
{
"code" : "29",
"display" : "CMVIG"
},
{
"code" : "56",
"display" : "dengue fever tetravalent"
},
{
"code" : "12",
"display" : "diphtheria antitoxin"
},
{
"code" : "28",
"display" : "DT (pediatric)"
},
{
"code" : "20",
"display" : "DTaP"
},
{
"code" : "106",
"display" : "DTaP, 5 pertussis antigens"
},
{
"code" : "107",
"display" : "DTaP, unspecified formulation"
},
{
"code" : "110",
"display" : "DTaP-Hep B-IPV"
},
{
"code" : "50",
"display" : "DTaP-Hib"
},
{
"code" : "120",
"display" : "DTaP-Hib-IPV"
},
{
"code" : "130",
"display" : "DTaP-IPV"
},
{
"code" : "1",
"display" : "DTP"
},
{
"code" : "22",
"display" : "DTP-Hib"
},
{
"code" : "102",
"display" : "DTP-Hib-Hep B"
},
{
"code" : "57",
"display" : "hantavirus"
},
{
"code" : "52",
"display" : "Hep A, adult"
},
{
"code" : "83",
"display" : "Hep A, ped/adol, 2 dose"
},
{
"code" : "84",
"display" : "Hep A, ped/adol, 3 dose"
},
{
"code" : "31",
"display" : "Hep A, pediatric, unspecified formulation"
},
{
"code" : "85",
"display" : "Hep A, unspecified formulation"
},
{
"code" : "104",
"display" : "Hep A-Hep B"
},
{
"code" : "30",
"display" : "HBIG"
},
{
"code" : "8",
"display" : "Hep B, adolescent or pediatric"
},
{
"code" : "42",
"display" : "Hep B, adolescent/high risk infant"
},
{
"code" : "43",
"display" : "Hep B, adult"
},
{
"code" : "44",
"display" : "Hep B, dialysis"
},
{
"code" : "45",
"display" : "Hep B, unspecified formulation"
},
{
"code" : "58",
"display" : "Hep C"
},
{
"code" : "59",
"display" : "Hep E"
},
{
"code" : "60",
"display" : "herpes simplex 2"
},
{
"code" : "46",
"display" : "Hib (PRP-D)"
},
{
"code" : "47",
"display" : "Hib (HbOC)"
},
{
"code" : "48",
"display" : "Hib (PRP-T)"
},
{
"code" : "49",
"display" : "Hib (PRP-OMP)"
},
{
"code" : "17",
"display" : "Hib, unspecified formulation"
},
{
"code" : "51",
"display" : "Hib-Hep B"
},
{
"code" : "61",
"display" : "HIV"
},
{
"code" : "118",
"display" : "HPV, bivalent"
},
{
"code" : "62",
"display" : "HPV, quadrivalent"
},
{
"code" : "86",
"display" : "IG"
},
{
"code" : "87",
"display" : "IGIV"
},
{
"code" : "14",
"display" : "IG, unspecified formulation"
},
{
"code" : "111",
"display" : "influenza, live, intranasal"
},
{
"code" : "15",
"display" : "influenza, split (incl. purified surface antigen)"
},
{
"code" : "16",
"display" : "influenza, whole"
},
{
"code" : "88",
"display" : "influenza, unspecified formulation"
},
{
"code" : "123",
"display" : "influenza, H5N1-1203"
},
{
"code" : "10",
"display" : "IPV"
},
{
"code" : "2",
"display" : "OPV"
},
{
"code" : "89",
"display" : "polio, unspecified formulation"
},
{
"code" : "39",
"display" : "Japanese encephalitis SC"
},
{
"code" : "63",
"display" : "Junin virus"
},
{
"code" : "64",
"display" : "leishmaniasis"
},
{
"code" : "65",
"display" : "leprosy"
},
{
"code" : "66",
"display" : "Lyme disease"
},
{
"code" : "3",
"display" : "MMR"
},
{
"code" : "4",
"display" : "M/R"
},
{
"code" : "94",
"display" : "MMRV"
},
{
"code" : "67",
"display" : "malaria"
},
{
"code" : "5",
"display" : "measles"
},
{
"code" : "68",
"display" : "melanoma"
},
{
"code" : "32",
"display" : "meningococcal MPSV4"
},
{
"code" : "103",
"display" : "meningococcal C conjugate"
},
{
"code" : "114",
"display" : "meningococcal MCV4P"
},
{
"code" : "108",
"display" : "meningococcal ACWY, unspecified formulation"
},
{
"code" : "7",
"display" : "mumps"
},
{
"code" : "69",
"display" : "parainfluenza-3"
},
{
"code" : "11",
"display" : "pertussis"
},
{
"code" : "23",
"display" : "plague"
},
{
"code" : "33",
"display" : "pneumococcal polysaccharide PPV23"
},
{
"code" : "100",
"display" : "pneumococcal conjugate PCV 7"
},
{
"code" : "109",
"display" : "pneumococcal, unspecified formulation"
},
{
"code" : "70",
"display" : "Q fever"
},
{
"code" : "18",
"display" : "rabies, intramuscular injection"
},
{
"code" : "40",
"display" : "rabies, intradermal injection"
},
{
"code" : "90",
"display" : "rabies, unspecified formulation"
},
{
"code" : "72",
"display" : "rheumatic fever"
},
{
"code" : "73",
"display" : "Rift Valley fever"
},
{
"code" : "34",
"display" : "RIG"
},
{
"code" : "119",
"display" : "rotavirus, monovalent"
},
{
"code" : "122",
"display" : "rotavirus, unspecified formulation"
},
{
"code" : "116",
"display" : "rotavirus, pentavalent"
},
{
"code" : "74",
"display" : "rotavirus, tetravalent"
},
{
"code" : "71",
"display" : "RSV-IGIV"
},
{
"code" : "93",
"display" : "RSV-MAb"
},
{
"code" : "6",
"display" : "rubella"
},
{
"code" : "38",
"display" : "rubella/mumps"
},
{
"code" : "76",
"display" : "Staphylococcus bacterio lysate"
},
{
"code" : "113",
"display" : "Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed"
},
{
"code" : "9",
"display" : "Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed"
},
{
"code" : "115",
"display" : "Tdap"
},
{
"code" : "35",
"display" : "tetanus toxoid, adsorbed"
},
{
"code" : "112",
"display" : "tetanus toxoid, unspecified formulation"
},
{
"code" : "77",
"display" : "Tick-borne encephalitis vaccine (non-US)"
},
{
"code" : "13",
"display" : "TIG"
},
{
"code" : "95",
"display" : "TST-OT tine test"
},
{
"code" : "96",
"display" : "TST-PPD intradermal"
},
{
"code" : "97",
"display" : "TST-PPD tine test"
},
{
"code" : "98",
"display" : "TST, unspecified formulation"
},
{
"code" : "78",
"display" : "tularemia vaccine"
},
{
"code" : "91",
"display" : "typhoid, unspecified formulation"
},
{
"code" : "25",
"display" : "typhoid, oral"
},
{
"code" : "41",
"display" : "typhoid, parenteral"
},
{
"code" : "53",
"display" : "typhoid, parenteral, AKD (U.S. military)"
},
{
"code" : "101",
"display" : "typhoid, ViCPs"
},
{
"code" : "75",
"display" : "vaccinia (smallpox)"
},
{
"code" : "105",
"display" : "vaccinia (smallpox) diluted"
},
{
"code" : "79",
"display" : "vaccinia immune globulin"
},
{
"code" : "21",
"display" : "varicella"
},
{
"code" : "81",
"display" : "VEE, inactivated"
},
{
"code" : "80",
"display" : "VEE, live"
},
{
"code" : "92",
"display" : "VEE, unspecified formulation"
},
{
"code" : "36",
"display" : "VZIG"
},
{
"code" : "117",
"display" : "VZIG (IND)"
},
{
"code" : "37",
"display" : "yellow fever"
},
{
"code" : "121",
"display" : "zoster live"
},
{
"code" : "998",
"display" : "no vaccine administered"
},
{
"code" : "999",
"display" : "unknown"
},
{
"code" : "99",
"display" : "RESERVED - do not use"
},
{
"code" : "133",
"display" : "Pneumococcal conjugate PCV 13"
},
{
"code" : "134",
"display" : "Japanese Encephalitis IM"
},
{
"code" : "137",
"display" : "HPV, unspecified formulation"
},
{
"code" : "136",
"display" : "Meningococcal MCV4O"
},
{
"code" : "135",
"display" : "Influenza, high dose seasonal"
},
{
"code" : "131",
"display" : "typhus, historical"
},
{
"code" : "132",
"display" : "DTaP-IPV-HIB-HEP B, historical"
},
{
"code" : "128",
"display" : "Novel Influenza-H1N1-09, all formulations"
},
{
"code" : "125",
"display" : "Novel Influenza-H1N1-09, nasal"
},
{
"code" : "126",
"display" : "Novel influenza-H1N1-09, preservative-free"
},
{
"code" : "127",
"display" : "Novel influenza-H1N1-09"
},
{
"code" : "138",
"display" : "Td (adult)"
},
{
"code" : "139",
"display" : "Td(adult) unspecified formulation"
},
{
"code" : "140",
"display" : "Influenza, seasonal, injectable, preservative free"
},
{
"code" : "129",
"display" : "Japanese Encephalitis, unspecified formulation"
},
{
"code" : "141",
"display" : "Influenza, seasonal, injectable"
},
{
"code" : "142",
"display" : "tetanus toxoid, not adsorbed"
},
{
"code" : "143",
"display" : "Adenovirus types 4 and 7"
},
{
"code" : "144",
"display" : "influenza, seasonal, intradermal, preservative free"
},
{
"code" : "145",
"display" : "RSV-MAb (new)"
},
{
"code" : "146",
"display" : "DTaP,IPV,Hib,HepB"
},
{
"code" : "147",
"display" : "meningococcal MCV4, unspecified formulation"
},
{
"code" : "148",
"display" : "Meningococcal C/Y-HIB PRP"
},
{
"code" : "149",
"display" : "influenza, live, intranasal, quadrivalent"
},
{
"code" : "150",
"display" : "influenza, injectable, quadrivalent, preservative free"
},
{
"code" : "151",
"display" : "influenza nasal, unspecified formulation"
},
{
"code" : "152",
"display" : "Pneumococcal Conjugate, unspecified formulation"
},
{
"code" : "153",
"display" : "Influenza, injectable, MDCK, preservative free"
},
{
"code" : "154",
"display" : "Hep A, IG"
},
{
"code" : "155",
"display" : "influenza, recombinant, injectable, preservative free"
},
{
"code" : "156",
"display" : "Rho(D)-IG"
},
{
"code" : "157",
"display" : "Rho(D) -IG IM"
},
{
"code" : "158",
"display" : "influenza, injectable, quadrivalent"
},
{
"code" : "159",
"display" : "Rho(D) - Unspecified formulation"
},
{
"code" : "160",
"display" : "Influenza A monovalent (H5N1), ADJUVANTED-2013"
},
{
"code" : "801",
"display" : "AS03 Adjuvant"
},
{
"code" : "161",
"display" : "Influenza, injectable,quadrivalent, preservative free, pediatric"
},
{
"code" : "162",
"display" : "meningococcal B, recombinant"
},
{
"code" : "163",
"display" : "meningococcal B, OMV"
},
{
"code" : "164",
"display" : "meningococcal B, unspecified"
},
{
"code" : "165",
"display" : "HPV9"
},
{
"code" : "166",
"display" : "influenza, intradermal, quadrivalent, preservative free"
},
{
"code" : "167",
"display" : "meningococcal, unknown serogroups"
},
{
"code" : "168",
"display" : "influenza, trivalent, adjuvanted"
},
{
"code" : "169",
"display" : "Hep A, live attenuated"
},
{
"code" : "170",
"display" : "DTAP/IPV/HIB - non-US"
},
{
"code" : "171",
"display" : "Influenza, injectable, MDCK, preservative free, quadrivalent"
},
{
"code" : "172",
"display" : "cholera, WC-rBS"
},
{
"code" : "173",
"display" : "cholera, BivWC"
},
{
"code" : "174",
"display" : "cholera, live attenuated"
},
{
"code" : "175",
"display" : "Rabies - IM Diploid cell culture"
},
{
"code" : "176",
"display" : "Rabies - IM fibroblast culture"
},
{
"code" : "177",
"display" : "PCV10"
},
{
"code" : "178",
"display" : "OPV bivalent"
},
{
"code" : "179",
"display" : "OPV ,monovalent, unspecified"
},
{
"code" : "180",
"display" : "tetanus immune globulin"
},
{
"code" : "181",
"display" : "anthrax immune globulin"
},
{
"code" : "182",
"display" : "OPV, Unspecified"
},
{
"code" : "183",
"display" : "Yellow fever vaccine - alt"
},
{
"code" : "184",
"display" : "Yellow fever, unspecified formulation"
},
{
"code" : "185",
"display" : "influenza, recombinant, quadrivalent,injectable, preservative free"
},
{
"code" : "186",
"display" : "Influenza, injectable, MDCK, quadrivalent, preservative"
},
{
"code" : "187",
"display" : "zoster recombinant"
},
{
"code" : "188",
"display" : "zoster, unspecified formulation"
},
{
"code" : "189",
"display" : "HepB-CpG"
},
{
"code" : "190",
"display" : "Typhoid conjugate vaccine (TCV)"
},
{
"code" : "191",
"display" : "meningococcal A polysaccharide (non-US)"
},
{
"code" : "192",
"display" : "meningococcal AC polysaccharide (non-US)"
},
{
"code" : "193",
"display" : "Hep A-Hep B, pediatric/adolescent"
},
{
"code" : "194",
"display" : "Influenza, Southern Hemisphere"
},
{
"code" : "195",
"display" : "DT, IPV adsorbed"
},
{
"code" : "196",
"display" : "Td, adsorbed, preservative free, adult use, Lf unspecified"
},
{
"code" : "197",
"display" : "influenza, high-dose, quadrivalent"
},
{
"code" : "200",
"display" : "influenza, Southern Hemisphere, pediatric, preservative free"
},
{
"code" : "201",
"display" : "influenza, Southern Hemisphere, preservative free"
},
{
"code" : "202",
"display" : "influenza, Southern Hemisphere, quadrivalent, with preservative"
},
{
"code" : "198",
"display" : "DTP-hepB-Hib Pentavalent Non-US"
},
{
"code" : "203",
"display" : "meningococcal conjugate quadrivalent, MenACWY-TT (MCV4)"
},
{
"code" : "205",
"display" : "Influenza vaccine, quadrivalent, adjuvanted"
},
{
"code" : "206",
"display" : "Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection"
},
{
"code" : "207",
"display" : "COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose"
},
{
"code" : "208",
"display" : "COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose"
},
{
"code" : "213",
"display" : "SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED"
},
{
"code" : "210",
"display" : "COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL "
},
{
"code" : "212",
"display" : "COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL"
},
{
"code" : "204",
"display" : "Ebola Zaire vaccine, live, recombinant, 1mL dose"
},
{
"code" : "214",
"display" : "Ebola, unspecified"
},
{
"code" : "211",
"display" : "COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL"
},
{
"code" : "500",
"display" : "COVID-19 Non-US Vaccine, Product Unknown"
},
{
"code" : "501",
"display" : "COVID-19 IV Non-US Vaccine (QAZCOVID-IN)"
},
{
"code" : "502",
"display" : "COVID-19 IV Non-US Vaccine (COVAXIN)"
},
{
"code" : "503",
"display" : "COVID-19 LAV Non-US Vaccine (COVIVAC)"
},
{
"code" : "504",
"display" : "COVID-19 VVnr Non-US Vaccine (Sputnik Light)"
},
{
"code" : "505",
"display" : "COVID-19 VVnr Non-US Vaccine (Sputnik V)"
},
{
"code" : "506",
"display" : "COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology"
},
{
"code" : "507",
"display" : "COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences)"
},
{
"code" : "508",
"display" : "COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention)"
},
{
"code" : "509",
"display" : "COVID-19 PS Non-US Vaccine (EpiVacCorona)"
},
{
"code" : "510",
"display" : "COVID-19 IV Non-US Vaccine (BIBP, Sinopharm)"
},
{
"code" : "511",
"display" : "COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac)"
},
{
"code" : "215",
"display" : "Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF"
},
{
"code" : "216",
"display" : "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF"
},
{
"code" : "219",
"display" : "COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose"
},
{
"code" : "217",
"display" : "COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose"
},
{
"code" : "218",
"display" : "COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose"
},
{
"code" : "220",
"display" : "HepB recombinant, 3-antigen, Al(OH)3"
},
{
"code" : "221",
"display" : "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose"
},
{
"code" : "222",
"display" : "Tick-borne encephalitis, unspecified"
},
{
"code" : "223",
"display" : "Tick-borne encephalitis, inactivated, PF, 0.25mL"
},
{
"code" : "224",
"display" : "Tick-borne encephalitis, inactivated, PF, 0.5mL"
},
{
"code" : "225",
"display" : "COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL"
},
{
"code" : "226",
"display" : "COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL"
},
{
"code" : "512",
"display" : "SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz)"
},
{
"code" : "513",
"display" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax)"
},
{
"code" : "514",
"display" : "SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D)"
},
{
"code" : "515",
"display" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901)"
},
{
"code" : "516",
"display" : "COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC)"
},
{
"code" : "517",
"display" : "SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax)"
},
{
"code" : "227",
"display" : "COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose"
},
{
"code" : "228",
"display" : "COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose"
},
{
"code" : "229",
"display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose"
},
{
"code" : "301",
"display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose"
},
{
"code" : "300",
"display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose"
},
{
"code" : "230",
"display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL"
},
{
"code" : "518",
"display" : "COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva)"
},
{
"code" : "519",
"display" : "COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna"
},
{
"code" : "520",
"display" : "COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech"
},
{
"code" : "521",
"display" : "COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK"
},
{
"code" : "231",
"display" : "influenza, Southern Hemisphere, high-dose, quadrivalent"
},
{
"code" : "303",
"display" : "RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF"
},
{
"code" : "304",
"display" : "Respiratory syncytial virus (RSV), unspecified "
},
{
"code" : "305",
"display" : "RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF"
},
{
"code" : "306",
"display" : "RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months"
},
{
"code" : "307",
"display" : "RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months"
},
{
"code" : "313",
"display" : "COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL"
},
{
"code" : "308",
"display" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL"
},
{
"code" : "309",
"display" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL"
},
{
"code" : "310",
"display" : "COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL"
},
{
"code" : "312",
"display" : "COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL"
},
{
"code" : "311",
"display" : "COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL"
},
{
"code" : "302",
"display" : "COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose"
}
]
}
]
}
}